Scientists hunt for simple blood clues to outsmart aggressive breast cancer
NCT ID NCT04068623
Summary
This study aims to find out if simple blood tests and tumor tissue analysis can help predict how patients with triple negative breast cancer will respond to treatment and their risk of the cancer returning. Researchers will observe 90 patients to see if certain blood cell counts and genetic markers in the blood correlate with treatment success and long-term outcomes. The goal is to gather knowledge that could lead to better tools for managing this aggressive cancer in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Jean PERRIN
Clermont-Ferrand, Please Select, 63000, France
Conditions
Explore the condition pages connected to this study.